{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:04:13Z","timestamp":1785261853733,"version":"3.55.0"},"reference-count":181,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":257,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC-2024-2790136"],"award-info":[{"award-number":["RC-2024-2790136"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:p>Thyroid cancer is the most prevalent endocrine malignancy. Distinct genetic alterations drive the development and progression of thyroid tumors of follicular cells with remarkable genotype\u2013phenotype correlation. In most tumors of follicular cell origin, the primary molecular events are RAS or RAS-like (follicular-patterned tumors) and BRAF p.V600E or BRAF V600E-like (conventional papillary carcinomas) alterations. Progression of thyroid tumors to advanced and less-differentiated carcinomas requires additional oncogenic alterations, including TP53 and TERT promoter mutation, and aberrant PI3K\u2013PTEN\u2013AKT signaling. Understanding the genetic landscape of thyroid carcinoma of follicular cells is essential to optimize clinical management and to identify molecular targets to treat cases with aggressive disease refractory to standard radioactive iodine therapy. What follows is a comprehensive and updated outline of the main somatic genetic and molecular alterations in thyroid carcinoma of follicular cells.<\/jats:p>","DOI":"10.1530\/etj-25-0104","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:55:21Z","timestamp":1761749721000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":9,"title":["Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells"],"prefix":"10.1530","volume":"14","author":[{"given":"Giulia","family":"Calafato","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-3865","authenticated-orcid":true,"given":"Floriana Jessica","family":"Di Paola","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Maloberti","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Coluccelli","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poppi","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Repaci","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Solaroli","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Damiani","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Chillotti","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Chiarucci","sequence":"additional","affiliation":[{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry Jane","family":"Rhoden","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[{"name":"3"},{"name":"8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2026070714020288300_bib1","volume-title":"Cancer today","author":"International Agency for Research on Cancer","year":"2024"},{"key":"2026070714020288300_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"2026070714020288300_bib3","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/CM9.0000000000003284","article-title":"Global burden of thyroid cancer in 2022: incidence and mortality estimates from GLOBOCAN","volume":"137","author":"Lyu","year":"2024","journal-title":"Chin Med J Engl"},{"key":"2026070714020288300_bib4","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04108","article-title":"Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories","volume":"13","author":"Wang","year":"2023","journal-title":"J Glob Health"},{"key":"2026070714020288300_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070714020288300_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070714020288300_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070714020288300_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"2026070714020288300_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"key":"2026070714020288300_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","article-title":"Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach","volume":"31","author":"Volante","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2026070714020288300_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2020.0668","article-title":"Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome","volume":"31","author":"Wong","year":"2021","journal-title":"Thyroid"},{"key":"2026070714020288300_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/his.14550","article-title":"Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases","volume":"80","author":"Xu","year":"2022","journal-title":"Histopathology"},{"key":"2026070714020288300_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12022-021-09664-3","article-title":"Genomics and epigenomics of medullary thyroid carcinoma: from sporadic disease to familial manifestations","volume":"32","author":"Barletta","year":"2021","journal-title":"Endocr Pathol"},{"key":"2026070714020288300_bib14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Investig"},{"key":"2026070714020288300_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.18632\/oncotarget.22805","article-title":"Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic papillary thyroid carcinomas","volume":"9","author":"Gandolfi","year":"2017","journal-title":"Oncotarget"},{"key":"2026070714020288300_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1158\/1535-7163.MCT-17-0871","article-title":"Molecular profile of advanced thyroid carcinomas by next-generation sequencing: characterizing tumors beyond diagnosis for targeted therapy","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"2026070714020288300_bib17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/er.2019-00007","article-title":"Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond","volume":"40","author":"Cabanillas","year":"2019","journal-title":"Endocr Rev"},{"key":"2026070714020288300_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2026070714020288300_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/his.13380","article-title":"Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance","volume":"72","author":"Acquaviva","year":"2018","journal-title":"Histopathology"},{"key":"2026070714020288300_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00428-023-03713-4","article-title":"Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance","volume":"484","author":"De Leo","year":"2024","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"2026070714020288300_bib22","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-04-3314","article-title":"Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells","volume":"65","author":"Mitsutake","year":"2005","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36922-1","article-title":"Recapitulating thyroid cancer histotypes through engineering embryonic stem cells","volume":"14","author":"Veschi","year":"2023","journal-title":"Nat Commun"},{"key":"2026070714020288300_bib24","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1158\/0008-5472.CAN-06-0171","article-title":"Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III","volume":"66","author":"Bonora","year":"2006","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib25","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","article-title":"Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors","volume":"104","author":"Gasparre","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070714020288300_bib26","doi-asserted-by":"crossref","first-page":"e38287","DOI":"10.1371\/journal.pone.0038287","article-title":"Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma","volume":"7","author":"Corver","year":"2012","journal-title":"PLoS One"},{"key":"2026070714020288300_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/gcc.22194","article-title":"Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations","volume":"53","author":"Corver","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"2026070714020288300_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of h\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","journal-title":"Cancer Cell"},{"key":"2026070714020288300_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"key":"2026070714020288300_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14796694.5.1.105","article-title":"Isoform-specific ras functions in development and cancer","volume":"5","author":"Quinlan","year":"2009","journal-title":"Future Oncol"},{"key":"2026070714020288300_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1947601911408081","article-title":"Functional specificity of ras isoforms: so similar but so different","volume":"2","author":"Castellano","year":"2011","journal-title":"Genes Cancer"},{"key":"2026070714020288300_bib32","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib33","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib34","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2002-021186","article-title":"Specific pattern of RAS oncogene mutations in follicular thyroid tumors","volume":"88","author":"Vasko","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026070714020288300_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2017.130","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists","volume":"31","author":"Seethala","year":"2018","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","article-title":"Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","journal-title":"Endocr Pathol"},{"key":"2026070714020288300_bib38","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"key":"2026070714020288300_bib39","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2012.0207","article-title":"Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series","volume":"23","author":"Ciampi","year":"2013","journal-title":"Thyroid"},{"key":"2026070714020288300_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.2023.0279","article-title":"Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study","volume":"34","author":"Xu","year":"2024","journal-title":"Thyroid"},{"key":"2026070714020288300_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0194599819842859","article-title":"Rethinking malignancy risk in indeterminate thyroid nodules with positive molecular studies: southern California permanente experience","volume":"161","author":"Cohen","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026070714020288300_bib43","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"2026070714020288300_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPAR \u03b3 1 fusion in oncogene human thyroid carcinoma","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"2026070714020288300_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2014.115","article-title":"Pax-8-PPAR-\u03b3 fusion protein in thyroid carcinoma","volume":"10","author":"Raman","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2026070714020288300_bib46","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2018-00277","article-title":"Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology","volume":"103","author":"Nicolson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib47","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1158\/0008-5472.CAN-08-1085","article-title":"CREB3L2-PPAR\u03b3 fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis","volume":"68","author":"Lui","year":"2008","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib48","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1210\/en.2011-1178","article-title":"Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPAR\u03b3 fusion protein thyroid carcinoma","volume":"152","author":"Dobson","year":"2011","journal-title":"Endocrinology"},{"key":"2026070714020288300_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/ERC-16-0043","article-title":"Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules","volume":"23","author":"Karunamurthy","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2026070714020288300_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-18-0606","article-title":"EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC","volume":"9","author":"Krishnamoorthy","year":"2019","journal-title":"Cancer Discov"},{"key":"2026070714020288300_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00428-024-03914-5","article-title":"EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices","volume":"485","author":"Abi-Raad","year":"2024","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib52","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","article-title":"Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers","volume":"24","author":"Pozdeyev","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026070714020288300_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"2026070714020288300_bib54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2026070714020288300_bib55","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1210\/jc.2006-2707","article-title":"BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism","volume":"92","author":"Durante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2016-2976","article-title":"The history of the follicular variant of papillary thyroid carcinoma","volume":"102","author":"Tallini","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib57","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","article-title":"BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer","volume":"90","author":"Xing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib58","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-005-1236-0","article-title":"Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients\u2019 age but not with tumour aggressiveness","volume":"446","author":"Trovisco","year":"2005","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.K08E-208","article-title":"BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients","volume":"56","author":"Yasuhiro","year":"2009","journal-title":"Endocr J"},{"key":"2026070714020288300_bib61","doi-asserted-by":"crossref","first-page":"E1745","DOI":"10.1210\/jc.2012-1526","article-title":"BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas","volume":"97","author":"Sancisi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/ERC-07-0130","article-title":"BRAFV600E mutation, but not RET\/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer","volume":"15","author":"Romei","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"2026070714020288300_bib63","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1245\/s10434-012-2851-z","article-title":"Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases","volume":"20","author":"Zheng","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026070714020288300_bib64","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12386","article-title":"The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?","volume":"80","author":"Walczyk","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2026070714020288300_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","article-title":"Association between BRAF V600E mutation and recurrence of papillary thyroid cancer","volume":"33","author":"Xing","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026070714020288300_bib66","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1530\/EJE-15-0605","article-title":"Endocrine tumours: genetic predictors of thyroid cancer outcome","volume":"174","author":"Tavares","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026070714020288300_bib67","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1210\/jc.2016-1775","article-title":"Papillary thyroid carcinoma with rare Exon 15 BRAF mutation has indolent behavior: a single-institution experience","volume":"101","author":"Torregrossa","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/cancers12020430","article-title":"BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: a search for the early molecular events associated with tumor development","volume":"12","author":"Acquaviva","year":"2020","journal-title":"Cancers"},{"key":"2026070714020288300_bib69","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/ijms24044057","article-title":"Expanding the spectrum of BRAF Non-V600E mutations in thyroid nodules: evidence-based data from a tertiary referral centre","volume":"24","author":"De Leo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026070714020288300_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature23291","article-title":"Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS","volume":"548","author":"Yao","year":"2017","journal-title":"Nature"},{"key":"2026070714020288300_bib71","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/genes11040424","article-title":"RET gene fusions in malignancies of the thyroid and other tissues","volume":"11","author":"Santoro","year":"2020","journal-title":"Genes"},{"key":"2026070714020288300_bib72","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.29887","article-title":"NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States","volume":"122","author":"Prasad","year":"2016","journal-title":"Cancer"},{"key":"2026070714020288300_bib73","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","article-title":"Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization","volume":"33","author":"Chu","year":"2020","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib74","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"2026070714020288300_bib75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12022-022-09739-9","article-title":"Kinase fusion-related thyroid carcinomas: towards predictive models for advanced actionable diagnostics","volume":"33","author":"Chu","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070714020288300_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100329","article-title":"A detailed histologic and molecular assessment of the diffuse sclerosing variant of papillary thyroid carcinoma","volume":"36","author":"Chou","year":"2023","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib77","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1245\/s10434-024-15500-9","article-title":"Defining the genomic landscape of diffuse sclerosing papillary thyroid carcinoma: prognostic implications of RET fusions","volume":"31","author":"Scholfield","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026070714020288300_bib78","first-page":"223","article-title":"RET\/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features","volume":"4","author":"Bongarzone","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2026070714020288300_bib79","first-page":"1457","article-title":"High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma","volume":"4","author":"Bongarzone","year":"1989","journal-title":"Oncogene"},{"key":"2026070714020288300_bib80","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1321937111","article-title":"Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer","volume":"111","author":"Kelly","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070714020288300_bib81","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/sj.onc.1203922","article-title":"The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium","volume":"19","author":"Russell","year":"2000","journal-title":"Oncogene"},{"key":"2026070714020288300_bib82","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.ajpath.2018.07.012","article-title":"Mouse model of poorly differentiated thyroid carcinoma driven by STRN-ALK fusion","volume":"188","author":"Nikitski","year":"2018","journal-title":"Am J Pathol"},{"key":"2026070714020288300_bib83","doi-asserted-by":"crossref","first-page":"e87170","DOI":"10.1371\/journal.pone.0087170","article-title":"Identification of a recurrent STRN\/ALK fusion in thyroid carcinomas","volume":"9","author":"P\u00e9rot","year":"2014","journal-title":"PLoS One"},{"key":"2026070714020288300_bib84","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1089\/thy.2011.0511","article-title":"Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors","volume":"22","author":"Hamatani","year":"2012","journal-title":"Thyroid"},{"key":"2026070714020288300_bib85","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/clinem\/dgab025","article-title":"Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology","volume":"106","author":"Chong","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib86","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2026070714020288300_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1083382","article-title":"DICER1 RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer","volume":"14","author":"Ricarte-Filho","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070714020288300_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1267499","article-title":"Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors","volume":"14","author":"Minna","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070714020288300_bib89","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.18632\/oncotarget.3593","article-title":"New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma","volume":"6","author":"Costa","year":"2015","journal-title":"Oncotarget"},{"key":"2026070714020288300_bib90","doi-asserted-by":"crossref","first-page":"e1006239","DOI":"10.1371\/journal.pgen.1006239","article-title":"Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers","volume":"12","author":"Yoo","year":"2016","journal-title":"PLoS Genet"},{"key":"2026070714020288300_bib91","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/jc.2017-02698","article-title":"DICER1 mutations are frequent in adolescent-onset papillary thyroid carcinoma","volume":"103","author":"Wasserman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/thy.2018.0607","article-title":"Macrofollicular variant of follicular thyroid carcinoma: a rare underappreciated pitfall in the diagnosis of thyroid carcinoma","volume":"30","author":"Bongiovanni","year":"2020","journal-title":"Thyroid"},{"key":"2026070714020288300_bib93","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41379-020-0458-7","article-title":"Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations","volume":"33","author":"Chernock","year":"2020","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib94","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/his.14416","article-title":"Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features","volume":"79","author":"Juhlin","year":"2021","journal-title":"Histopathology"},{"key":"2026070714020288300_bib95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00428-021-03212-4","article-title":"Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform","volume":"480","author":"Ghossein","year":"2022","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib96","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jamaoncol.2022.1655","article-title":"Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children","volume":"8","author":"Gallant","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026070714020288300_bib97","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1210\/clinem\/dgae034","article-title":"Prevalence, molecular landscape, and clinical impact of DICER1 and DGCR8 mutated follicular-patterned thyroid nodules","volume":"109","author":"Condello","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00428-024-03802-y","article-title":"Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study","volume":"485","author":"Condello","year":"2024","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/thy.2024.0556","article-title":"Letter to the editor: morphological indicators of DICER1 mutations may guide somatic and germline testing","volume":"35","author":"Juhlin","year":"2025","journal-title":"Thyroid"},{"key":"2026070714020288300_bib100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00428-020-02853-1","article-title":"Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term \u201cthyroblastoma\u201d more appropriate?","volume":"477","author":"Agaimy","year":"2020","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib101","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/PAS.0000000000001430","article-title":"Recurrent DICER1 hotspot mutations in malignant thyroid gland teratomas: molecular characterization and proposal for a separate classification","volume":"44","author":"Rooper","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"2026070714020288300_bib102","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/humu.23877","article-title":"Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes","volume":"40","author":"Kock","year":"2019","journal-title":"Hum Mutat"},{"key":"2026070714020288300_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.path.2022.09.010","article-title":"On the chopping block: overview of DICER1 mutations in endocrine and neuroendocrine neoplasms","volume":"16","author":"Juhlin","year":"2023","journal-title":"Surg Pathol Clin"},{"key":"2026070714020288300_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.727970","article-title":"Prevalence of pathogenic germline DICER1 variants in young individuals thyroidectomised due to goitre \u2013 a national Danish cohort","volume":"12","author":"Altaraihi","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070714020288300_bib105","first-page":"253","article-title":"Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors","volume":"66","author":"Tallini","year":"1994","journal-title":"Cytogenet Cell Genet"},{"key":"2026070714020288300_bib106","first-page":"547","article-title":"Frequent chromosomal DNA unbalance in thyroid oncocytic (h\u00fcrthle cell) neoplasms detected by comparative genomic hybridization","volume":"79","author":"Tallini","year":"1999","journal-title":"Lab Invest"},{"key":"2026070714020288300_bib107","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)61132-7","article-title":"Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on H\u00fcrthle cell tumors","volume":"160","author":"M\u00e1ximo","year":"2002","journal-title":"Am J Pathol"},{"key":"2026070714020288300_bib108","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.22569","article-title":"Copy number variations identified in thyroid FNA specimens are associated with H\u00fcrthle cell cytomorphology","volume":"130","author":"Abi-Raad","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"2026070714020288300_bib109","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0047","article-title":"A clinically applicable molecular classification of oncocytic cell thyroid nodules","volume":"30","author":"de Koster","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026070714020288300_bib110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19880101)61:1<110::AID-CNCR2820610119>3.0.CO;2-4","article-title":"Cytophotometric measurements of h\u00fcrthle cell tumors of the thyroid gland. Correlation with pathologic features and clinical behavior","volume":"61","author":"Flint","year":"1988","journal-title":"Cancer"},{"key":"2026070714020288300_bib111","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/365649a0","article-title":"Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas","volume":"365","author":"Parma","year":"1993","journal-title":"Nature"},{"key":"2026070714020288300_bib112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s001090000170","article-title":"Detection of thyroid-stimulating hormone receptor and Gs \u03b1 mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis","volume":"78","author":"Tr\u00fclzsch","year":"2001","journal-title":"J Mol Med Berl"},{"key":"2026070714020288300_bib113","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1530\/eje.1.02253","article-title":"Similar prevalence of somatic TSH receptor and Gs\u03b1 mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey","volume":"155","author":"Gozu","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2026070714020288300_bib114","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s001090050141","article-title":"Mutations of thyrotropin receptor gene","volume":"75","author":"Porcellini","year":"1997","journal-title":"J Mol Med Berl"},{"key":"2026070714020288300_bib115","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI84894","article-title":"Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas","volume":"126","author":"Calebiro","year":"2016","journal-title":"J Clin Investig"},{"key":"2026070714020288300_bib116","first-page":"400","article-title":"Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?","volume":"12","author":"Cameselle-Teijeiro","year":"1999","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib117","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2559.1994.tb01374.x","article-title":"Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm","volume":"25","author":"Harach","year":"1994","journal-title":"Histopathology"},{"key":"2026070714020288300_bib118","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-004-7475-4","article-title":"Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer","volume":"28","author":"Tomoda","year":"2004","journal-title":"World J Surg"},{"key":"2026070714020288300_bib119","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","article-title":"Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/\u03b2-catenin pathway","volume":"31","author":"Cameselle-Teijeiro","year":"2018","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","article-title":"Cribriform-morular thyroid carcinoma is a distinct thyroid malignancy of uncertain cytogenesis","volume":"32","author":"Boyraz","year":"2021","journal-title":"Endocr Pathol"},{"key":"2026070714020288300_bib121","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64821-3","article-title":"Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis","volume":"157","author":"Miyaki","year":"2000","journal-title":"Am J Pathol"},{"key":"2026070714020288300_bib122","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/path.1225","article-title":"Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene","volume":"199","author":"Xu","year":"2003","journal-title":"J Pathol"},{"key":"2026070714020288300_bib123","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hed.27025","article-title":"American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: defining advanced thyroid cancer and its targeted treatment","volume":"44","author":"Shonka","year":"2022","journal-title":"Head Neck"},{"key":"2026070714020288300_bib124","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","article-title":"Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing","volume":"24","author":"Kunstman","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2026070714020288300_bib125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/gcc.22678","article-title":"Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor","volume":"57","author":"Dong","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"2026070714020288300_bib126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00428-020-02891-9","article-title":"Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature","volume":"478","author":"Ragazzi","year":"2021","journal-title":"Virchows Arch"},{"key":"2026070714020288300_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10680-5","article-title":"Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer","volume":"10","author":"Yoo","year":"2019","journal-title":"Nat Commun"},{"key":"2026070714020288300_bib128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"key":"2026070714020288300_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat Commun"},{"key":"2026070714020288300_bib130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Investig"},{"key":"2026070714020288300_bib131","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2026070714020288300_bib132","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1158\/0008-5472.CAN-04-4259","article-title":"Mutation of the PIK3CA gene in anaplastic thyroid cancer","volume":"65","author":"Garc\u00eda-Rost\u00e1n","year":"2005","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib133","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2008-0273","article-title":"Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase\/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers","volume":"93","author":"Liu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib134","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib135","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41388-017-0088-9","article-title":"MicroRNA-146b promotes PI3K\/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN","volume":"37","author":"Ram\u00edrez-Moya","year":"2018","journal-title":"Oncogene"},{"key":"2026070714020288300_bib136","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1158\/0008-5472.CAN-09-0024","article-title":"Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo","volume":"69","author":"Miller","year":"2009","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib137","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1210\/en.2013-1028","article-title":"Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer","volume":"154","author":"Sponziello","year":"2013","journal-title":"Endocrinology"},{"key":"2026070714020288300_bib138","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4172\/2155-9899.1000451","article-title":"Immune suppression mediated by Myeloid and lymphoid derived immune cells in the tumor microenvironment facilitates progression of thyroid cancers driven by HrasG12V and pten loss","volume":"7","author":"Jolly","year":"2016","journal-title":"J Clin Cell Immunol"},{"key":"2026070714020288300_bib139","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1158\/1541-7786.MCR-14-0158-T","article-title":"Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis","volume":"12","author":"Charles","year":"2014","journal-title":"Mol Cancer Res"},{"key":"2026070714020288300_bib140","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","article-title":"Fibroblast-mediated collagen remodeling within the tumor microenvironment facilitates progression of thyroid cancers driven by BrafV600E and pten loss","volume":"76","author":"Jolly","year":"2016","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201365","article-title":"Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels","volume":"13","author":"Shimamura","year":"2018","journal-title":"PLoS One"},{"key":"2026070714020288300_bib142","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers15030879","article-title":"Development of Novel Murine BRAFV600E-Driven papillary thyroid cancer cell lines for modeling of disease progression and preclinical evaluation of therapeutics","volume":"15","author":"Branigan","year":"2023","journal-title":"Cancers"},{"key":"2026070714020288300_bib143","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.18632\/oncotarget.380","article-title":"Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors","volume":"2","author":"Arciuch","year":"2011","journal-title":"Oncotarget"},{"key":"2026070714020288300_bib144","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/1078-0432.CCR-11-0933","article-title":"Synergistic action of a RAF inhibitor and a dual PI3K\/mTOR inhibitor in thyroid cancer","volume":"17","author":"Jin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2026070714020288300_bib145","doi-asserted-by":"crossref","first-page":"24604","DOI":"10.18632\/oncotarget.15599","article-title":"Combined MEK and Pi3\u2019-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo","volume":"8","author":"ElMokh","year":"2017","journal-title":"Oncotarget"},{"key":"2026070714020288300_bib146","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/1078-0432.CCR-14-1814","article-title":"A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1\/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors","volume":"21","author":"Bedard","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026070714020288300_bib147","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"2026070714020288300_bib148","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"2026070714020288300_bib149","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","article-title":"Mutant p53 as a guardian of the cancer cell","volume":"26","author":"Mantovani","year":"2019","journal-title":"Cell Death Differ"},{"key":"2026070714020288300_bib150","first-page":"1369","article-title":"Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland","volume":"52","author":"Dohi","year":"1992","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib151","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI116168","article-title":"High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas","volume":"91","author":"Fagin","year":"1993","journal-title":"J Clin Investig"},{"key":"2026070714020288300_bib152","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.onc.1200979","article-title":"p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thryroid cells","volume":"14","author":"Yang","year":"1997","journal-title":"Oncogene"},{"key":"2026070714020288300_bib153","first-page":"2029","article-title":"A mutated p53 gene alters thyroid cell differentiation","volume":"11","author":"Battista","year":"1995","journal-title":"Oncogene"},{"key":"2026070714020288300_bib154","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9440(10)64577-4","article-title":"Loss of p53 promotes anaplasia and local invasion in ret\/PTC1-induced thyroid carcinomas","volume":"157","author":"La Perle","year":"2000","journal-title":"Am J Pathol"},{"key":"2026070714020288300_bib155","doi-asserted-by":"crossref","first-page":"E1600","DOI":"10.1073\/pnas.1404357111","article-title":"p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer","volume":"111","author":"McFadden","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026070714020288300_bib156","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/onc.2015.253","article-title":"TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer","volume":"35","author":"Zou","year":"2016","journal-title":"Oncogene"},{"key":"2026070714020288300_bib157","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1172\/JCI120966","article-title":"Hgf\/met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers","volume":"128","author":"Knauf","year":"2018","journal-title":"J Clin Investig"},{"key":"2026070714020288300_bib158","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1158\/0008-5472.CAN-17-1925","article-title":"Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers","volume":"78","author":"Untch","year":"2018","journal-title":"Cancer Res"},{"key":"2026070714020288300_bib159","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/ERC-14-0268","article-title":"Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression","volume":"21","author":"Champa","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"2026070714020288300_bib160","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1089\/thy.2019.0284","article-title":"Mouse model of thyroid cancer progression and dedifferentiation driven by STRN-ALK expression and loss of p53: evidence for the existence of two types of poorly differentiated carcinoma","volume":"29","author":"Nikitski","year":"2019","journal-title":"Thyroid"},{"key":"2026070714020288300_bib161","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins","volume":"11","author":"Mart\u00ednez","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2026070714020288300_bib162","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"key":"2026070714020288300_bib163","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tig.2013.06.007","article-title":"Telomerase at the intersection of cancer and aging","volume":"29","author":"Bernardes de Jesus","year":"2013","journal-title":"Trends Genet"},{"key":"2026070714020288300_bib164","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070714020288300_bib165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"2026070714020288300_bib166","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"2026070714020288300_bib167","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"key":"2026070714020288300_bib168","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"2026070714020288300_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"2026070714020288300_bib170","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020288300_bib171","article-title":"Exploring the role of TERT in thyroid cancer: a systematic review","volume":"213","author":"Maloberti","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026070714020288300_bib172","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","article-title":"Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations","volume":"35","author":"Park","year":"2022","journal-title":"Mod Pathol"},{"key":"2026070714020288300_bib173","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer \u2013 biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2026070714020288300_bib174","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.stem.2016.03.001","article-title":"Suppression of the SWI\/SNF component Arid1a promotes Mammalian regeneration","volume":"18","author":"Sun","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2026070714020288300_bib175","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.celrep.2017.01.058","article-title":"Composition and function of mutant Swi\/Snf complexes","volume":"18","author":"Dutta","year":"2017","journal-title":"Cell Rep"},{"key":"2026070714020288300_bib176","doi-asserted-by":"crossref","first-page":"E4951","DOI":"10.1073\/pnas.1702723114","article-title":"Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene","volume":"114","author":"Montero-Conde","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070714020288300_bib177","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/2159-8290.CD-20-0735","article-title":"SWI\/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies","volume":"11","author":"Saqcena","year":"2021","journal-title":"Cancer Discov"},{"key":"2026070714020288300_bib178","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.2021.0565","article-title":"Enhancing radioiodine incorporation in BRAF-Mutant, radioiodine-refractory thyroid cancers with vemurafenib and the Anti-ErbB3 monoclonal antibody CDX-3379: results of a pilot clinical trial","volume":"32","author":"Tchekmedyian","year":"2022","journal-title":"Thyroid"},{"key":"2026070714020288300_bib179","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"key":"2026070714020288300_bib180","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/2159-8290.CD-15-0330","article-title":"NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition","volume":"5","author":"Garcia-Rendueles","year":"2015","journal-title":"Cancer Discov"},{"key":"2026070714020288300_bib181","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","article-title":"Genomic alterations in fatal forms of non-anaplastic thyroid cancer: identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence","volume":"23","author":"Ibrahimpasic","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/5\/ETJ-25-0104.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/5\/ETJ-25-0104.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0104\/506836\/etj-25-0104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0104\/506836\/etj-25-0104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:02:32Z","timestamp":1783447352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/5\/e250104\/75676\/Somatic-genetic-alterations-in-the-development-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":181,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0104","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"e250104"}}